Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 258  

    Article Cited by others


Studies on the labeling of Ethylenediaminetetramethylene phosphonic acid, Methylene Diphosphonate, Sodium pyrophosphate and Hydroxyapatite with Lutetium-177 for use in nuclear medicine

Abbasi Imtiaz Ahmed

Year : 2015| Volume: 14| Issue : 2 | Page no: 95-100

   This article has been cited by
1 Comparative studies on the potential use of 177Lu-based radiopharmaceuticals for the palliative therapy of bone metastases
Hesham M. H. Zakaly,Mostafa Y. A. Mostafa,Darya Deryabina,Michael Zhukovsky
International Journal of Radiation Biology. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Investigation of 177Lu-labeled HEDP, DPD, and IDP as potential bone pain palliation agents
Marija Mirkovic,Zorana Milanovic,Dalibor Stankovic,Đorde Petrovic,Sanja Vranješ-Đuric,Drina Jankovic,Magdalena Radovic
Journal of Radiation Research and Applied Sciences. 2020; 13(1): 27
[Pubmed]  [Google Scholar] [DOI]
3 Radiotheranostics with radiolanthanides: Design, development strategies, and medical applications
Kenji Mishiro,Hirofumi Hanaoka,Aiko Yamaguchi,Kazuma Ogawa
Coordination Chemistry Reviews. 2019; 383: 104
[Pubmed]  [Google Scholar] [DOI]


Read this article